EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:5000 - fenfluramine
| Formula | C12H16F3N |
| Net Charge | 0 |
| Average Mass | 231.261 |
| Monoisotopic Mass | 231.12348 |
| SMILES | CCNC(C)Cc1cccc(C(F)(F)F)c1 |
| InChI | InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3 |
| InChIKey | DBGIVFWFUFKIQN-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | serotonergic agonist An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders. anti-obesity agent Any substance which is used to reduce or control weight. serotonin uptake inhibitor A compound that specifically inhibits the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent. |
| Applications: | serotonergic agonist An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders. appetite depressant Any agent that is used to decrease appetite. anticonvulsant A drug used to prevent seizures or reduce their severity. antispasmodic drug A drug that suppresses spasms. These are usually caused by smooth muscle contraction, especially in tubular organs. The effect is to prevent spasms of the stomach, intestine or urinary bladder. serotonin uptake inhibitor A compound that specifically inhibits the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| fenfluramine (CHEBI:5000) has role anti-obesity agent (CHEBI:74518) |
| fenfluramine (CHEBI:5000) has role anticonvulsant (CHEBI:35623) |
| fenfluramine (CHEBI:5000) has role antispasmodic drug (CHEBI:53784) |
| fenfluramine (CHEBI:5000) has role appetite depressant (CHEBI:50507) |
| fenfluramine (CHEBI:5000) has role serotonergic agonist (CHEBI:35941) |
| fenfluramine (CHEBI:5000) has role serotonin uptake inhibitor (CHEBI:50949) |
| fenfluramine (CHEBI:5000) is a (trifluoromethyl)benzenes (CHEBI:83565) |
| fenfluramine (CHEBI:5000) is a secondary amino compound (CHEBI:50995) |
| Incoming Relation(s) |
| fenfluramine hydrochloride (CHEBI:59729) has part fenfluramine (CHEBI:5000) |
| (R)-fenfluramine (CHEBI:521051) is a fenfluramine (CHEBI:5000) |
| (S)-fenfluramine (CHEBI:439329) is a fenfluramine (CHEBI:5000) |
| IUPAC Name |
|---|
| N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine |
| INNs | Source |
|---|---|
| fenfluramina | WHO MedNet |
| fenfluramine | ChemIDplus |
| fenfluraminum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 1-(m-trifluoromethyl-phenyl)-2-ethylaminopropane | ChemIDplus |
| 2-ethylamino-1-(3-trifluoromethylphenyl)propane | ChemIDplus |
| 3-(trifluoromethyl)-N-ethyl-α-methylphenethylamine | NIST Chemistry WebBook |
| Acino | ChEMBL |
| Brabafen | ChEMBL |
| N-ethyl-α-methyl-3-trifluoromethylphenethylamine | NIST Chemistry WebBook |
| Manual Xrefs | Databases |
|---|---|
| 1150 | DrugCentral |
| C06996 | KEGG COMPOUND |
| D07945 | KEGG DRUG |
| DB00574 | DrugBank |
| Fenfluramine | Wikipedia |
| HMDB0015322 | HMDB |
| US3198833 | Patent |
| Citations |
|---|